Micafungin Teva

Micafungin, the active ingredient in Micafungin Teva, is an echinocandin presented as an injection for intravenous use. It treats invasive fungal infections such as candidiasis in immunocompromised patients, including those undergoing chemotherapy or stem‑cell transplantation.

GNH USA supplies Micafungin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Micafungin is an echinocandin antifungal used to treat serious fungal infections.

- Invasive candidiasis: effective treatment of bloodstream and deep‑tissue Candida infections. - Esophageal candidiasis: eradicates Candida infection of the esophagus in adults. - Prophylaxis of fungal infections in hematopoietic stem cell transplantation: prevents invasive candidiasis during the transplant period. - Febrile neutropenia: empirical therapy for suspected fungal infection in neutropenic patients.

Micafungin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Fever: transient temperature rise during infusion. - Nausea: mild gastrointestinal upset. - Headache: occasional mild to moderate headache. - Elevated liver enzymes: transient increase in ALT or AST.

Serious or Rare Side Effects: - Severe hepatic failure: rare but may require discontinuation. - Anaphylaxis: acute hypersensitivity reaction with rash, bronchospasm, or hypotension. - Stevens‑Johnson syndrome: severe skin reaction requiring urgent care.

Use micafungin with careful clinical monitoring and consider patient‑specific factors.

- Liver function monitoring: assess baseline and periodic liver enzymes. - Renal function assessment: evaluate creatinine clearance before initiation. - Hypersensitivity caution: discontinue if signs of allergic reaction appear. - Hepatic impairment dose adjustment: consider reduced exposure in severe liver disease. - Storage: Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with several co‑administered medicines; clinical judgment is required.

Major Interactions (Avoid): - Cyclosporine: increased micafungin exposure may raise toxicity risk. - Rifampin: strong enzyme induction can markedly reduce micafungin levels.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole): potential additive hepatotoxicity. - Statins (e.g., simvastatin): monitor liver function tests. - Immunosuppressants (e.g., tacrolimus): observe for altered drug concentrations.